Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00465881 · ClinicalTrials.gov registry record
Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes
A clinical trial, sponsored by HealthPartners Institute.
- Completed
- Registry status
- 30
- Enrollment target
NCT00465881 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 30 participants.
The verdict
NCT00465881 has completed, sponsored by HealthPartners Institute.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain sufficient continuous glucose monitoring (CGM) data in a manner that provides clinical information that is not available using conventional self-monitored blood glucose. Currently, a formal method does not exist for evaluating CGM data except for looking at each glucose reading across the days a CGM system has been worn and evaluating it based on clinical practice experience. The hope is that a mathematical model can be developed that will enable health care providers to quickly and easily determine what changes in diabetes treatment need to be made after CGM data is obtained.
Interventions
- DEVICE CGM System for Type 1 and Type 2 Diabetes Mellitus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-01 |
| Est. Completion | 2006-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00465881
The ClinicalTrials.gov registry entry for NCT00465881 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CGM System for Type 1 and Type 2 Diabetes Mellitus is the first listed.
NCT00465881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00465881 about?
NCT00465881 is a clinical study titled "Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes". The purpose of this study is to obtain sufficient continuous glucose monitoring (CGM) data in a manner that provides clinical information that is not available using conventional self-monitored blood glucose. Currently, a formal method does not exist for evaluating CGM data except for looking at eac...
What is the current status of trial NCT00465881?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-01. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00465881?
The interventions under investigation include: CGM System for Type 1 and Type 2 Diabetes Mellitus (DEVICE).
Who is sponsoring clinical trial NCT00465881?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.